Capecitabine: all 1,069 studies that test it

Page 3 of 11. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.

• Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer PatientTerminatedNCT01955629Phase 1/2Results posted
• Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast CancerStatus unknownNCT01928680Phase 2Results posted
• Capecitabine With Digoxin for Metastatic Breast CancerTerminatedNCT01887288Phase 2Results posted
• Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast CancerTerminatedNCT01873833Phase 2Results posted
• Phase II Trial for Large ER-Negative Breast CancersCompletedNCT01869192Phase 2Results posted
• Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal AdenocarcinomaTerminatedNCT01844076Phase 1/2Results posted
• Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body WeightCompletedNCT01828554Not applicableResults posted
• Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsCompletedNCT01824875Phase 2Results posted
• Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the SkinTerminatedNCT01823679Phase 2Results posted
• A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.CompletedNCT01783444Phase 2Results posted
• GTX-RT in Borderline Resectable Pancreatic CancerTerminatedNCT01754623Phase 2Results posted
• A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal CancerTerminatedNCT01729923Phase 2Results posted
• Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal CancerCompletedNCT01722162Phase 2Results posted
• Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard TherapiesTerminatedNCT01705106Phase 1Results posted
• A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)TerminatedNCT01702558Phase 2Results posted
• Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal CancerCompletedNCT01661972Phase 1/2Results posted
• Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver MetastasesCompletedNCT01643070Phase 2Results posted
• Safety Study of Capecitabine With Radiation in Elderly Rectal CancerCompletedNCT01584544Phase 1Results posted
• Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine TumorsCompletedNCT01525082Phase 2Results posted
• Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast CancerCompletedNCT01498458Phase 1Results posted
• HKI-272 for HER2-Positive Breast Cancer and Brain MetastasesCompletedNCT01494662Phase 2Results posted
• Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic CancerCompletedNCT01494155Phase 2Results posted
• Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal CancerCompletedNCT01471353Phase 2Results posted
• Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid MalignanciesCompletedNCT01463982Phase 1Results posted
• Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic CancerCompletedNCT01459614Phase 2Results posted
• A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction CancerTerminatedNCT01450696Phase 3Results posted
• Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast CancerCompletedNCT01439282Phase 2Results posted
• Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic DiseaseCompletedNCT01387295Phase 2Results posted
• A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib ProtocolsTerminatedNCT01369433Not applicableResults posted
• Gemcitabine/Capecitabine Followed by SBRT in Pancreatic AdenocarcinomaCompletedNCT01360593Phase 2Results posted
• E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric CancerTerminatedNCT01355302Phase 1/2Results posted
• Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast CancerCompletedNCT01326481Phase 1/2Results posted
• A Confirmation Study of Eribulin in Combination With CapecitabineCompletedNCT01323530Phase 1/2Results posted
• A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.TerminatedNCT01290718Phase 2Results posted
• Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal CancerTerminatedNCT01280643Not applicableResults posted
• Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer PatientsCompletedNCT01268943Phase 1Results posted
• Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerTerminatedNCT01267240Phase 2Results posted
• A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.CompletedNCT01227707Phase 2Results posted
• A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid TumorsCompletedNCT01226732Phase 1Results posted
• Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater AdenocarcinomaCompletedNCT01208103Phase 2Results posted
• Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver TransplantationTerminatedNCT01151761Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.CompletedNCT01135498Phase 2Results posted
• A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the RectumTerminatedNCT01134601Phase 1Results posted
• A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric CancerCompletedNCT01130337Phase 2Results posted
• A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid TumorCompletedNCT01128842Phase 1Results posted
• A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem GliomasCompletedNCT01118377Phase 2Results posted
• Trial of Vinflunine Plus Capecitabine in Advanced Breast CancerCompletedNCT01095003Phase 3Results posted
• Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube CancerActive, not recruitingNCT01081262Phase 3Results posted
• A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and AvastinCompletedNCT01077739Phase 2Results posted
• Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal CancerCompletedNCT01060007Phase 2Results posted
• Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and NeckCompletedNCT01044433Phase 2Results posted
• Sorafenib With Capecitabine for Patients With Measurable Hepatocellular CarcinomaTerminatedNCT01032850Phase 2Results posted
• Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryCompletedNCT01013649Phase 3Results posted
• A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile DuctsCompletedNCT01007552Phase 2Results posted
• Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB)CompletedNCT00996333Phase 2Results posted
• A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain MetastasisTerminatedNCT00977379Phase 2Results posted
• Sunitinib and Capecitabine for First Line Colon CancerTerminatedNCT00961571Phase 2Results posted
• Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast CancerTerminatedNCT00959946Phase 1/2Results posted
• Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00938470Phase 2Results posted
• A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast CancerCompletedNCT00929240Phase 3Results posted
• ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic CancerCompletedNCT00925769Phase 1Results posted
• Xeloda (Capecitabine) and External Beam RadiationCompletedNCT00916578Phase 2Results posted
• Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic CancerTerminatedNCT00889187Phase 1/2Results posted
• A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast CancerCompletedNCT00885755Phase 2Results posted
• A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic CancerCompletedNCT00882310Phase 2Results posted
• Lapatinib and Capecitabine for Second Line Treatment of Pancreas CancerTerminatedNCT00881621Phase 2Results posted
• Capecitabine and Temozolomide for Neuroendocrine CancersCompletedNCT00869050Phase 2Results posted
• Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric CancerCompletedNCT00842244Phase 1Results posted
• A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast CancerCompletedNCT00811135Phase 2Results posted
• A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal CancerCompletedNCT00796718Phase 2Results posted
• S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile DuctCompletedNCT00789958Phase 2Results posted
• Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver CancerTerminatedNCT00787787Phase 2Results posted
• Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric CarcinomaCompletedNCT00780494Phase 2Results posted
• Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast CancerCompletedNCT00741260Phase 1/2Results posted
• Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ AdenocarcinomaCompletedNCT00737438Phase 2Results posted
• Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast CancerCompletedNCT00721630Phase 2Results posted
• Study of Capecitabine to Treat Recurrent High Grade GliomasCompletedNCT00717197Phase 2Results posted
• S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal CancerCompletedNCT00686166Phase 2Results posted
• Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal AdenocarcinomaTerminatedNCT00667420Phase 1/2Results posted
• Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryTerminatedNCT00665457Phase 2Results posted
• Study Of Sunitinib With Capecitabine In Breast CancerCompletedNCT00662025Phase 2Results posted
• CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary CarcinomaCompletedNCT00634751Phase 1/2Results posted
• Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerTerminatedNCT00634088Phase 1Results posted
• LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer PatientsCompletedNCT00632489Phase 1Results posted
• Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal AdenocarcinomaTerminatedNCT00625183Phase 2Results posted
• A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal CancerCompletedNCT00623805Phase 3Results posted
• Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal CancerCompletedNCT00613080Phase 2Results posted
• Perioperative Therapy for Resectable Pancreatic CancerCompletedNCT00609336Phase 2Results posted
• 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus BevacizumabCompletedNCT00600340Phase 3Results posted
• Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT00585078Phase 2Results posted
• Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal CancerCompletedNCT00578071Phase 1/2Results posted
• OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.CompletedNCT00577031Phase 4Results posted
• A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.TerminatedNCT00576901Phase 2Results posted
• Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal AdenocarcinomaCompletedNCT00574171Phase 2Results posted
• Brain Mets - Capecitabine Plus Sunitinib and WBRTTerminatedNCT00570908Phase 2Results posted
• A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast CancerCompletedNCT00568022Phase 1Results posted
• Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XPCompletedNCT00565370Phase 1/2Results posted
• Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After SurgeryCompletedNCT00562718Phase 2Results posted
• Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan TreatmentTerminatedNCT00538291Phase 2Results posted
• Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal CancerCompletedNCT00536809Phase 1Results posted

← Capecitabine overview